And there is also a completed phase I/II clinical trial of E6 TCR-T cells combined with lymphocyte depletion and IL2 for patients with metastatic HPV 16-positive cancer that had received prior platinum-based therapy (NCT02280811). This evidence concerns the gene IL2 and cancer.